IPO Details
Bidding Dates
28 Jun 24 - 02 Jul 24
Price Range ₹
85 - 90
Total Equity
₹ 41.26Cr
Lot Size
1600
Exchange Status
NSE
IPO Doc
Subscription Rate
Non-Institutional Investor
0.00×
Qualified Institutional Buyers
0.00×
Employees
0.00×
Retail Investors
0.00×
Total subscription Rate
0.00×
IPO Timeline
Offer start
28 Jun 2024
Offer end
02 Jul 2024
Allotment
03 Jul 2024
Refund initiation
04 Jul 2024
Demat transfer
04 Jul 2024
Listing
05 Jul 2024
Offer start
28 Jun 2024
Offer end
02 Jul 2024
Allotment
03 Jul 2024
Refund initiation
04 Jul 2024
Demat transfer
04 Jul 2024
Listing
05 Jul 2024
About Company
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center in Kolkata, offering a wide range of clinical and lifestyle solutions, including renal insufficiency treatments. Supported by expert doctors, experienced paramedical professionals, and a skilled management team, Nephro Care provides healthcare services to around 900 Chronic Kidney Disease patients monthly. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. Services are delivered from its main Salt Lake clinic, spanning 5,352 square feet, and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal. Nephro Care offers the following services: - In-house Dialysis Unit - Outpatient Services in Nephrology, Diabetology, Cardiology, Ophthalmology, and Neurology - NABL accredited in-house Pathology - In-house Pharmacy - Advanced Diagnostic Facilities - Renal Nutrition Department - Home Care - Mukti (Lifestyle Support Program) - Home Dialysis As of March 31, 2024, the hospital employs 110 people across various departments.
Year Founded
08-07-2014
Promotor Details
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 85.02 | 0 |
| Share Capital | 10120000 | 0 |
Offer to Public
45,84,000.00 Cr
Highlights
- Developed portable RO system for dialysis-ready water.
- Innovative app for remote consultations, showing significant growth.
- Steady increase in revenue from Rs 1.82 crore in 2021 to Rs 19.75 crore in 2023.
- Efficient clinic operation with skilled professionals and advanced infrastructure.
- Converting a 60-bed hospital into a 100-bed multi-speciality facility.
Challenges
- Telemedicine app still in beta, not fully launched.
- Major growth and services concentrated in Kolkata.
- High costs associated with hospital expansion and technology deployment.
- Facing competition from established healthcare providers.
- Healthcare spending can be sensitive to economic fluctuations.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2022 | 462.93 | 50.00 | 450.24 | 441.14 | 3.7828 |
| 2021 | 112.55 | 1.00 | 450.24 | 441.14 | 3.7828 |
| 2023 | 816.65 | 50.00 | 8.87 | 8.87 | 4.435 |
| 2024 | 2,088.25 | 1,190.24 | -0.98 | -0.98 | -0.0098 |
